Bone Biologics - Warrants (13/10/2026) Common Stock

As of the most recent data (June 2026), BBLGW shows a common stock of $1.8K. That compares with $1.7K in the prior-year period — up 7.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBLGW's common stock is now $1.8K (was $1.7K) — a 7.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bone Biologics - Warrants (13/10/2026) is outperforming or lagging.

Tracking BBLGW's common stock over time shows whether Bone Biologics - Warrants (13/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8K That compares with $1.7K in the prior-year period — up 7.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Bone Biologics - Warrants (13/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $1.8K) with ownership activity and broader fundamentals.